Linda M Niccolai1, Caitlin E Hansen2. 1. Connecticut Emerging Infections Program and Yale Cancer Center, Center for Interdisciplinary Research on AIDS, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut. 2. Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
Abstract
IMPORTANCE: Vaccines against human papillomavirus (HPV) are recommended for routine use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal. Educational interventions focused on parents and patients to increase coverage have not generally demonstrated effectiveness. OBJECTIVE: To systematically review the literature on effectiveness of interventions conducted at the practice or community level to increase uptake of HPV vaccines in the United States. EVIDENCE REVIEW: Keyword searches of the PubMed, Web of Science, and MEDLINE databases identified studies of adolescents that included the outcome of HPV vaccination published through July 2014. References of identified articles were also reviewed. A total of 366 records were screened, 38 full-text articles were reviewed, and 14 published studies were included. Results were summarized by different intervention approaches. FINDINGS: Practice- and community-based intervention approaches included reminder and recall (n = 7), physician-focused interventions (eg, audit and feedback) (n = 6), school-based programs (n = 2), and social marketing (n = 2) (2 interventions tested multiple approaches). Seven studies used a randomized design, and 8 used quasiexperimental approaches (one used both). Thirteen studies included girls, and 2 studies included boys. Studies were conducted in a variety of populations and geographic locations. Twelve studies reported significant increases in at least one HPV vaccination outcome, one reported a nonsignificant increase, and one reported mixed effects. CONCLUSIONS AND RELEVANCE: Most practice- and community-based interventions significantly increased HPV vaccination rates using varied approaches across diverse populations. This finding is in stark contrast to a recent review that did not find effects to warrant widespread implementation for any educational intervention. To address the current suboptimal rates of HPV vaccination in the United States, future efforts should focus on programs that can be implemented within health care settings, such as reminder and recall strategies and physician-focused efforts, as well as the use of alternative community-based locations, such as schools.
IMPORTANCE: Vaccines against human papillomavirus (HPV) are recommended for routine use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal. Educational interventions focused on parents and patients to increase coverage have not generally demonstrated effectiveness. OBJECTIVE: To systematically review the literature on effectiveness of interventions conducted at the practice or community level to increase uptake of HPV vaccines in the United States. EVIDENCE REVIEW: Keyword searches of the PubMed, Web of Science, and MEDLINE databases identified studies of adolescents that included the outcome of HPV vaccination published through July 2014. References of identified articles were also reviewed. A total of 366 records were screened, 38 full-text articles were reviewed, and 14 published studies were included. Results were summarized by different intervention approaches. FINDINGS: Practice- and community-based intervention approaches included reminder and recall (n = 7), physician-focused interventions (eg, audit and feedback) (n = 6), school-based programs (n = 2), and social marketing (n = 2) (2 interventions tested multiple approaches). Seven studies used a randomized design, and 8 used quasiexperimental approaches (one used both). Thirteen studies included girls, and 2 studies included boys. Studies were conducted in a variety of populations and geographic locations. Twelve studies reported significant increases in at least one HPV vaccination outcome, one reported a nonsignificant increase, and one reported mixed effects. CONCLUSIONS AND RELEVANCE: Most practice- and community-based interventions significantly increased HPV vaccination rates using varied approaches across diverse populations. This finding is in stark contrast to a recent review that did not find effects to warrant widespread implementation for any educational intervention. To address the current suboptimal rates of HPV vaccination in the United States, future efforts should focus on programs that can be implemented within health care settings, such as reminder and recall strategies and physician-focused efforts, as well as the use of alternative community-based locations, such as schools.
Authors: Elaine C Matheson; Anne Derouin; Martha Gagliano; Julie A Thompson; Jane Blood-Siegfried Journal: J Pediatr Health Care Date: 2013-11-05 Impact factor: 1.812
Authors: Alexander G Fiks; Robert W Grundmeier; Stephanie Mayne; Lihai Song; Kristen Feemster; Dean Karavite; Cayce C Hughes; James Massey; Ron Keren; Louis M Bell; Richard Wasserman; A Russell Localio Journal: Pediatrics Date: 2013-05-06 Impact factor: 7.124
Authors: Peter G Szilagyi; Christina Albertin; Sharon G Humiston; Cynthia M Rand; Stanley Schaffer; Howard Brill; Joseph Stankaitis; Byung-Kwang Yoo; Aaron Blumkin; Shannon Stokley Journal: Acad Pediatr Date: 2013-01-09 Impact factor: 3.107
Authors: Peter G Szilagyi; Sharon G Humiston; Sarah Gallivan; Christina Albertin; Martha Sandler; Aaron Blumkin Journal: Arch Pediatr Adolesc Med Date: 2011-06
Authors: Susan Hariri; Elizabeth R Unger; Maya Sternberg; Eileen F Dunne; David Swan; Sonya Patel; Lauri E Markowitz Journal: J Infect Dis Date: 2011-08-15 Impact factor: 5.226
Authors: K Syrjänen; M Hakama; S Saarikoski; M Väyrynen; M Yliskoski; S Syrjänen; V Kataja; O Castrén Journal: Sex Transm Dis Date: 1990 Jan-Mar Impact factor: 2.830
Authors: Heather M Brandt; Robin C Vanderpool; Susan J Curry; Paige Farris; Jason Daniel-Ulloa; Laura Seegmiller; Lindsay R Stradtman; Thuy Vu; Victoria Taylor; Maria Zubizarreta Journal: Hum Vaccin Immunother Date: 2019-06-03 Impact factor: 3.452
Authors: Vivian Colón-López; Meredith S Shiels; Mark Machin; Ana P Ortiz; Howard Strickler; Philip E Castle; Ruth M Pfeiffer; Eric A Engels Journal: J Clin Oncol Date: 2017-11-15 Impact factor: 44.544
Authors: Natoshia M Askelson; Grace Ryan; Laura Seegmiller; Felicia Pieper; Bethany Kintigh; Donald Callaghan Journal: J Community Health Date: 2019-08
Authors: Richard K Zimmerman; Jonathan M Raviotta; Mary Patricia Nowalk; Krissy K Moehling; Evelyn Cohen Reis; Sharon G Humiston; Chyongchiou Jeng Lin Journal: Vaccine Date: 2017-09-22 Impact factor: 3.641
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641